Which has preferable valuation and earnings, SOLV or MDLN?

Solventum has higher earnings, but lower revenue than Medline. Solventum is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solventum $8.33B 1.79 $1.56B $8.18 10.69 Medline $28.43B 1.50 $1.16B $0.79 41.18

Is SOLV or MDLN more profitable?

Solventum has a net margin of 17.26% compared to Medline's net margin of 0.00%. Solventum's return on equity of 25.09% beat Medline's return on equity. Company Net Margins Return on Equity Return on Assets Solventum 17.26% 25.09% 8.78% Medline N/A N/A N/A

Does the media prefer SOLV or MDLN?

In the previous week, Medline had 4 more articles in the media than Solventum. MarketBeat recorded 11 mentions for Medline and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Medline's score of 1.05 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medline 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has higher earnings & valuation, ALC or SOLV?

Solventum has lower revenue, but higher earnings than Alcon. Solventum is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.86B 3.01 $980M $1.31 50.43 Solventum $8.33B 1.79 $1.56B $8.18 10.69

Is ALC or SOLV more profitable?

Solventum has a net margin of 17.26% compared to Alcon's net margin of 5.92%. Solventum's return on equity of 25.09% beat Alcon's return on equity. Company Net Margins Return on Equity Return on Assets Alcon 5.92% 7.29% 5.09% Solventum 17.26% 25.09% 8.78%

Does the media favor ALC or SOLV?

In the previous week, Solventum had 5 more articles in the media than Alcon. MarketBeat recorded 7 mentions for Solventum and 2 mentions for Alcon. Solventum's average media sentiment score of 1.34 beat Alcon's score of -0.50 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Solventum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SOLV or WST?

In the previous week, West Pharmaceutical Services had 8 more articles in the media than Solventum. MarketBeat recorded 15 mentions for West Pharmaceutical Services and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat West Pharmaceutical Services' score of 0.88 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 9 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to COO or SOLV?

In the previous week, Cooper Companies had 69 more articles in the media than Solventum. MarketBeat recorded 76 mentions for Cooper Companies and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Cooper Companies' score of 0.21 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 16 Very Positive mention(s) 7 Positive mention(s) 20 Neutral mention(s) 16 Negative mention(s) 6 Very Negative mention(s) Neutral Solventum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ALGN or SOLV?

In the previous week, Align Technology had 6 more articles in the media than Solventum. MarketBeat recorded 13 mentions for Align Technology and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Align Technology's score of 1.23 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Solventum (SOLV) Competitors

$87.43 -0.22 (-0.26%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$87.44 +0.01 (+0.01%)

As of 09/11/2026 07:37 PM Eastern

Compare

SOLV vs. MDLN, ALC, WST, COO, and ALGN

Should you buy Solventum stock or one of its competitors? Solventum's main competitors and comparable companies include Medline (MDLN), Alcon (ALC), West Pharmaceutical Services (WST), Cooper Companies (COO), and Align Technology (ALGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Solventum compare to Medline?

Solventum (NYSE:SOLV) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Solventum has higher earnings, but lower revenue than Medline. Solventum is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.79	$1.56B	$8.18	10.69
Medline	$28.43B	1.50	$1.16B	$0.79	41.18

Solventum has a net margin of 17.26% compared to Medline's net margin of 0.00%. Solventum's return on equity of 25.09% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.26%	25.09%	8.78%
Medline	N/A	N/A	N/A

In the previous week, Medline had 4 more articles in the media than Solventum. MarketBeat recorded 11 mentions for Medline and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Medline's score of 1.05 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medline	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Solventum presently has a consensus target price of $92.80, indicating a potential upside of 6.15%. Medline has a consensus target price of $47.42, indicating a potential upside of 45.78%. Given Medline's stronger consensus rating and higher possible upside, analysts plainly believe Medline is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

Summary

Solventum and Medline tied by winning 7 of the 14 factors compared between the two stocks.

How does Solventum compare to Alcon?

Alcon (NYSE:ALC) and Solventum (NYSE:SOLV) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

In the previous week, Solventum had 5 more articles in the media than Alcon. MarketBeat recorded 7 mentions for Solventum and 2 mentions for Alcon. Solventum's average media sentiment score of 1.34 beat Alcon's score of -0.50 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Solventum	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Solventum has a net margin of 17.26% compared to Alcon's net margin of 5.92%. Solventum's return on equity of 25.09% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	5.92%	7.29%	5.09%
Solventum	17.26%	25.09%	8.78%

Solventum has lower revenue, but higher earnings than Alcon. Solventum is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.86B	3.01	$980M	$1.31	50.43
Solventum	$8.33B	1.79	$1.56B	$8.18	10.69

Alcon currently has a consensus target price of $84.96, suggesting a potential upside of 28.60%. Solventum has a consensus target price of $92.80, suggesting a potential upside of 6.15%. Given Alcon's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alcon is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.61
Solventum	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58

53.9% of Alcon shares are held by institutional investors. 1.5% of Alcon shares are held by company insiders. Comparatively, 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alcon has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Solventum has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

Summary

Alcon beats Solventum on 10 of the 17 factors compared between the two stocks.

How does Solventum compare to West Pharmaceutical Services?

Solventum (NYSE:SOLV) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

Solventum has a net margin of 17.26% compared to West Pharmaceutical Services' net margin of 16.98%. Solventum's return on equity of 25.09% beat West Pharmaceutical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.26%	25.09%	8.78%
West Pharmaceutical Services	16.98%	20.11%	14.83%

Solventum presently has a consensus price target of $92.80, suggesting a potential upside of 6.15%. West Pharmaceutical Services has a consensus price target of $373.85, suggesting a potential upside of 8.21%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87

Solventum has higher revenue and earnings than West Pharmaceutical Services. Solventum is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.79	$1.56B	$8.18	10.69
West Pharmaceutical Services	$3.33B	7.31	$493.70M	$7.81	44.24

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.2% of Solventum shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Solventum has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market.

In the previous week, West Pharmaceutical Services had 8 more articles in the media than Solventum. MarketBeat recorded 15 mentions for West Pharmaceutical Services and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat West Pharmaceutical Services' score of 0.88 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	9 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats Solventum on 11 of the 17 factors compared between the two stocks.

How does Solventum compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Solventum (NYSE:SOLV) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Cooper Companies currently has a consensus target price of $71.47, suggesting a potential upside of 32.57%. Solventum has a consensus target price of $92.80, suggesting a potential upside of 6.15%. Given Cooper Companies' higher possible upside, equities analysts plainly believe Cooper Companies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	2 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.17
Solventum	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 0.2% of Solventum shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 69 more articles in the media than Solventum. MarketBeat recorded 76 mentions for Cooper Companies and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Cooper Companies' score of 0.21 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	16 Very Positive mention(s)	7 Positive mention(s)	20 Neutral mention(s)	16 Negative mention(s)	6 Very Negative mention(s)	Neutral
Solventum	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Solventum has a net margin of 17.26% compared to Cooper Companies' net margin of 13.46%. Solventum's return on equity of 25.09% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	13.46%	10.90%	7.24%
Solventum	17.26%	25.09%	8.78%

Cooper Companies has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, Solventum has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

Solventum has higher revenue and earnings than Cooper Companies. Solventum is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.24B	2.48	$374.90M	$2.93	18.40
Solventum	$8.33B	1.79	$1.56B	$8.18	10.69

Summary

Solventum beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Solventum compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Solventum (NYSE:SOLV) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Align Technology currently has a consensus target price of $206.36, suggesting a potential upside of 36.82%. Solventum has a consensus target price of $92.80, suggesting a potential upside of 6.15%. Given Align Technology's stronger consensus rating and higher probable upside, research analysts clearly believe Align Technology is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Solventum	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58

Solventum has higher revenue and earnings than Align Technology. Solventum is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.61	$410.35M	$5.75	26.23
Solventum	$8.33B	1.79	$1.56B	$8.18	10.69

In the previous week, Align Technology had 6 more articles in the media than Solventum. MarketBeat recorded 13 mentions for Align Technology and 7 mentions for Solventum. Solventum's average media sentiment score of 1.34 beat Align Technology's score of 1.23 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.4% of Align Technology shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.2% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market. Comparatively, Solventum has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Solventum has a net margin of 17.26% compared to Align Technology's net margin of 9.99%. Solventum's return on equity of 25.09% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Solventum	17.26%	25.09%	8.78%

Summary

Align Technology beats Solventum on 10 of the 16 factors compared between the two stocks.

Get Solventum News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SOLV vs. The Competition

Export

Metric	Solventum	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$14.92B	$5.44B	$7.15B	$23.18B
Dividend Yield	N/A	1.79%	2.56%	3.56%
P/E Ratio	10.69	25.09	274.95	28.71
Price / Sales	1.79	82.90	656.56	94.44
Price / Cash	9.75	32.53	77.04	33.82
Price / Book	3.00	5.97	10.33	4.74
Net Income	$1.56B	$150.75M	$3.50B	$1.07B
7 Day Performance	-4.66%	-2.83%	-3.32%	-2.00%
1 Month Performance	2.23%	-3.09%	-0.41%	-2.69%
1 Year Performance	19.23%	9.34%	19.21%	10.45%

Solventum Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SOLV Solventum	2.0086 of 5 stars	$87.43 -0.3%	$92.80 +6.1%	+18.6%	$14.92B	$8.33B	10.69	20,000	News Coverage Positive News Analyst Upgrade
MDLN Medline	3.6123 of 5 stars	$36.59 flat	$47.42 +29.6%	N/A	$48.11B	$28.43B	46.32	45,000	Positive News
ALC Alcon	3.1607 of 5 stars	$70.54 +0.1%	$84.96 +20.4%	-17.0%	$34.87B	$10.40B	53.85	25,942
WST West Pharmaceutical Services	3.6606 of 5 stars	$339.90 0.0%	$368.08 +8.3%	+31.1%	$23.93B	$3.07B	43.52	10,800	Analyst Forecast Insider Trade
COO Cooper Companies	3.9297 of 5 stars	$69.59 flat	$81.64 +17.3%	-21.3%	$13.57B	$4.09B	58.97	15,000	Trending News Earnings Report Analyst Forecast Buyback Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SOLV) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solventum (SOLV) Competitors

SOLV vs. MDLN, ALC, WST, COO, and ALGN

How does Solventum compare to Medline?

Summary

How does Solventum compare to Alcon?

Summary

How does Solventum compare to West Pharmaceutical Services?

Summary

How does Solventum compare to Cooper Companies?

Summary

How does Solventum compare to Align Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SOLV vs. The Competition

Solventum Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solventum (SOLV) Competitors

SOLV vs. MDLN, ALC, WST, COO, and ALGN

How does Solventum compare to Medline?

Which has preferable valuation and earnings, SOLV or MDLN?

Is SOLV or MDLN more profitable?

Does the media prefer SOLV or MDLN?

Do analysts prefer SOLV or MDLN?

Summary

How does Solventum compare to Alcon?

Does the media favor ALC or SOLV?

Is ALC or SOLV more profitable?

Which has higher earnings & valuation, ALC or SOLV?

Do analysts rate ALC or SOLV?

Do insiders & institutionals have more ownership in ALC or SOLV?

Which has more risk & volatility, ALC or SOLV?

Summary

How does Solventum compare to West Pharmaceutical Services?

Is SOLV or WST more profitable?

Do analysts recommend SOLV or WST?

Which has stronger earnings and valuation, SOLV or WST?

Do insiders & institutionals have more ownership in SOLV or WST?

Which has more volatility and risk, SOLV or WST?

Does the media refer more to SOLV or WST?

Summary

How does Solventum compare to Cooper Companies?

Do analysts recommend COO or SOLV?

Do insiders & institutionals have more ownership in COO or SOLV?

Does the media refer more to COO or SOLV?

Is COO or SOLV more profitable?

Which has more risk & volatility, COO or SOLV?

Which has better valuation & earnings, COO or SOLV?

Summary

How does Solventum compare to Align Technology?

Do analysts recommend ALGN or SOLV?

Which has better earnings and valuation, ALGN or SOLV?

Does the media refer more to ALGN or SOLV?

Do insiders & institutionals have more ownership in ALGN or SOLV?

Which has more volatility and risk, ALGN or SOLV?

Is ALGN or SOLV more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SOLV vs. The Competition

Solventum Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools